Intelligent, Integrated and Autonomous Pharmaceutical Manufacturing: From Molecule to Medicine through Connected Platforms, AI and Self-Driving Technologies
September 28 - 30 • 2026 • Ghent • Belgium
13th pan-European Science Conference on QbD & PAT
EuPAT 13 will bring together scientists, engineers, technology developers, and regulatory experts from academia and industry to explore the next generation of intelligent, integrated and autonomous pharmaceutical development and manufacturing.
The conference will focus on how batch, mini-batch and continuous manufacturing platforms, combined with end-to-end integration, automation and digitalization, are transforming the way drug substances and drug products are developed and produced. Particular emphasis will be placed on integrated development–manufacturing platforms, self-driving laboratories, and disruptive manufacturing concepts, including point-of-care and decentralized production technologies.
Across three scientific sessions and a hands-on workshop, EuPAT 13 will showcase cutting-edge academic research and industrial development and case studies covering:
- Next-generation sensors, advanced PAT tools and innovative QbD strategies, supporting real-time monitoring, intelligent control and robust, flexible manufacturing across batch, mini-batch and continuous processes
- Integrated and autonomous pharmaceutical platforms, connecting drug substance and drug product development through end-to-end manufacturing
- Artificial intelligence across the pharmaceutical lifecycle, enabling predictive modeling, data-driven decision making and autonomous operation
The program will highlight real-world implementation, data-driven and automated control strategies, and the role of advanced sensing, data integration and digital platforms in enabling intelligent and autonomous manufacturing. Regulatory perspectives on the adoption of AI, PAT, QbD and autonomous systems will be addressed, with a focus on ensuring product quality, robustness and patient safety in future-proof manufacturing environments.
In addition to invited lectures and contributed oral presentations, poster sessions will provide extensive opportunities for scientific exchange, networking, and discussion of emerging technologies shaping the future of pharmaceutical manufacturing.
